Fundraising FoxSDIC Venture Capital — Full Portfolio
2 tracked investments · listed companies and verified rows first
Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSuzhou, CN
Dr. Long-Cheng Li(CEO and Founder)Dr. Moorim Kang(Chief Technology Officer)
Co-investorsEisai Innovation, Inc.
Biocytogen (HKEX: 02315) is a global biotechnology company that uses genetically engineered mouse models and its RenMice/RenMab/RenNano fully human antibody platforms to develop therapeutic antibody drugs.
BiotechDeep TechHealthtechBeijing, CN
Yuelei Shen(Founder)in
Co-investorsCowin Capital Group3E Bioventures CapitalOriza Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.